<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31454197</article-id><article-id pub-id-type="pmc">6713373</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2018-0398</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>The Effect of Continuous Ventilation on Thiol-Disulphide Homeostasis
and Albumin-Adjusted Ischemia-Modified Albumin During Cardiopulmonary
Bypass</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ozgunay</surname><given-names>Seyda Efsun</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-5933-9322</contrib-id><name><surname>Ozsin</surname><given-names>Kadir Kaan</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="c1"/><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Ustundag</surname><given-names>Yasemin</given-names></name><xref ref-type="aff" rid="aff3">3</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Karasu</surname><given-names>Derya</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Ozyaprak</surname><given-names>Buket</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Balc&#x00131;</surname><given-names>Burak</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Erel</surname><given-names>Ozcan</given-names></name><xref ref-type="aff" rid="aff4">4</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Yavuz</surname><given-names>Senol</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib></contrib-group><aff id="aff1">
<label>1</label> Department of Anesthesiology, University of Health Sciences, Bursa
Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey.</aff><aff id="aff2">
<label>2</label> Department of Cardiovascular Surgery,University of Health Sciences,
Bursa Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey.</aff><aff id="aff3">
<label>3</label> Department of Medical Biochemistry, University of Health Sciences,
Bursa Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey.</aff><aff id="aff4">
<label>4</label> Department of Medical Biochemistry, University of Health Sciences,
Ankara D&#x00131;skapi Y&#x00131;ld&#x00131;r&#x00131;m Beyaz&#x00131;t Research and
Education Hospital, Ankara, Turkey.</aff><author-notes><corresp id="c1">Correspondence Address: Kadir Kaan Ozsin,
https://orcid.org/0000-0001-5933-9322, Department of Cardiovascular Surgery,
University of Health Sciences, Bursa Yuksek Ihtisas Training and Research
Hospital, Mimar Sinan Mahallesi, Emniyet Caddesi 35, Polis Okulu
Kar&#x0015f;&#x00131;s&#x00131;, Yildirim/Bursa, Turkey, Zip Code: 16320. E-mail:
<email>kkozsin@gmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Jul-Aug</season><year>2019</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Jul-Aug</season><year>2019</year></pub-date><volume>34</volume><issue>4</issue><fpage>436</fpage><lpage>443</lpage><history><date date-type="received"><day>05</day><month>12</month><year>2018</year></date><date date-type="accepted"><day>28</day><month>1</month><year>2019</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Objective</title><p>To investigate the effect of continuous lung ventilation with low tidal
volume on oxidation parameters, such as thiol/disulphide homeostasis and
albumin-adjusted ischemia-modified albumin (AAIMA), during cardiopulmonary
bypass (CBP) in coronary artery bypass grafting (CABG).</p></sec><sec><title>Methods</title><p>Seventy-four patients who underwent elective CABG with CPB were included in
the study. Blood samples were taken in the preoperative period, 10 minutes
after CPB, and six and 24 hours postoperatively. Patients were assigned to
the continuous ventilation group (Group 1, n=37) and the non-ventilated
group (Group 2, n=37). The clinical characteristics, thiol/disulphide
homeostasis, ischemia-modified albumin (IMA), and AAIMA levels of the
patients were compared.</p></sec><sec><title>Results</title><p>A significant difference was found between the groups regarding native thiol,
total thiol, and IMA levels at the postoperative 24<sup>th</sup> hour
(<italic>P</italic>=0.030, <italic>P</italic>=0.031, and
<italic>P</italic>=0.004, respectively). There was no difference between
the groups in terms of AAIMA. AAIMA levels returned to preoperative levels
in Groups 1 and 2, at the 6<sup>th</sup> and 24<sup>th</sup> postoperative
hours, respectively. Length of hospital stay was significantly shorter in
Group 1 (<italic>P</italic>&#x0003c;0.001) than in Group 2.</p></sec><sec><title>Conclusion</title><p>Continuous ventilation during CPB caused an increase in native and total
thiol levels, an earlier return of AAIMA levels, and shorter hospital stay.
Continuous ventilation may reduce the negative effects of CPB on myocardium
(Table 2, Figure 1, and Reference 31).</p></sec></abstract><kwd-group><kwd>Coronary Artery Bypass</kwd><kwd>Mechanical Ventilation</kwd><kwd>Ischemia-Modified Albumin</kwd><kwd>Disulfides</kwd><kwd>Sulfhydryl Compounds</kwd><kwd>Biomarkers</kwd></kwd-group></article-meta></front><body><table-wrap id="t3" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="42%" span="1"/><col width="5%" span="1"/><col width="5%" span="1"/><col width="42%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="background-color:#e6e7e8" rowspan="1">Abbreviations,
acronyms &#x00026; symbols</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th><th align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</th><th align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</th></tr></thead><tbody><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">AAIMA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Albumin-adjusted
ischemia-modified albumin</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ICU</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Intensive care unit</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ABSU</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Absorbance units</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">IMA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Ischemia-modified
albumin</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ASA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= American Society of
Anesthesiologists</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">I/R</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">=
Ischemia/reperfusion</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">BSA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Body surface area</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">MI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Myocardial injury</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CABG</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Coronary artery bypass
grafting</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PEEP</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Positive end expiratory
pressure</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CAD</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Coronary artery
disease</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">SD</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Standard deviation</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CPB</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Cardiopulmonary
bypass</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">SH total SH</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Native thiol/total thiol
percent ratio</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">EF</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Ejection fraction</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">SPSS</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Statistical Package for
the Social Sciences</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">EuroSCORE</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= European System for
Cardiac Operative Risk Evaluation</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">SS total SH</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Disulfide/total thiol
percent ratio</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">FiO<sub>2</sub></td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Fraction of inspired
oxygen</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">SSSH</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Disulphide/native thiol
ratio</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Coronary artery bypass grafting (CABG) surgery is one of the major surgeries with
high postoperative complications, mortality, and morbidity. Ischemia created during
this process and following reperfusion can damage the myocardium. Inflammatory and
systemic oxidative stress response caused by total cardiopulmonary bypass (CPB)
causes endothelial damage in many systemic organs<sup>[<xref rid="r1" ref-type="bibr">1</xref>-<xref rid="r3" ref-type="bibr">3</xref>]</sup>, and this mechanism has
been not fully explained yet. In addition, alveolar collapse, change in compliance
of the chest wall, diaphragmatic dysfunction, lung and phrenic nerve trauma,
splanchnic hypoperfusion, pulmonary ischemia/reperfusion (I/R), and use of protamine
are also causes of the ischemic condition. Hemolysis in CABG activates neutrophils
and the oxidative system and affects the myocardium, lungs, and kidneys by causing
protein and lipid peroxidation and deoxyribonucleic acid oxidation, which affect
clinical outcomes<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>.</p><p>Decreased myocardial blood flow causes the formation of ischemia-modified albumin
(IMA) by causing hypoxia, acidosis, an increase in reactive oxygen derivatives, and
change in serum albumin<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup>. IMA, which reflects myocardial ischemia in minutes,
shows the short-term oxidative effect<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>. The albumin-adjusted ischemia-modified albumin
(AAIMA) level is also used because IMA levels may be affected by changes in the
concentration of albumin<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>. Thiols are sulphur group-containing compounds,
which are essential antioxidant buffers that interact with almost all physiologic
oxidants<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>. Thiol groups are oxidized by oxidant molecules in
the surroundings and converted to disulphide structures and then to thiol groups,
thereby forming the equilibrium of thiol/disulphide. Thiol/disulphide homeostasis
plays an important role in vital functions and antioxidant
protection<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>.</p><p>Due to the fact that the heart is the most exposed organ to severe I/R, various
studies have investigated the relationship between CABG, various CBP systems,
surgical methods, anesthesia methods, administration of trace elements and vitamin
supplements to patients, and the antioxidant status of
patients<sup>[<xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r10" ref-type="bibr">10</xref>]</sup>. Although there are many studies on continuous
ventilation in CABG, randomized studies are limited<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup>. In light of these
studies, ventilation appears to be beneficial in the long term in total CPB. In the
literature, no study has shown the effect of continuous ventilation during total CPB
on thiol/disulphide homeostasis, IMA, and AAIMA levels.</p><p>It is known that continuous ventilation during CABG decreases the blood flow to the
bronchial artery, reduces ischemia, and enables better inspiratory capacity by
reducing lung damage<sup>[<xref rid="r12" ref-type="bibr">12</xref>-<xref rid="r15" ref-type="bibr">15</xref>]</sup>. In this study, we aimed to investigate the effect
of continuous lung ventilation with low tidal volume on oxidation parameters, such
as thiol/disulphide homeostasis, IMA, and AAIMA levels, during CBP in CABG.</p></sec><sec sec-type="methods"><title>METHODS</title><sec><title>Study Design and Patient Selection</title><p>The study protocol was approved by the local Ethics Committee. Written informed
consent was obtained from patients. The study was conducted in accordance with
the principles of the Declaration of Helsinki. This prospective, randomized,
single-center, double-blinded study was carried out between January 2018 and
June 2018. The physician who evaluated the patients and their laboratory results
were blinded to the study.</p><p>Patients with the American Society of Anesthesiologists (ASA) physical status
III-IV who were aged 50-70 years and underwent elective CABG with CPB were
included in the study. Smokers, patients who had not smoked for less than five
years, patients with diabetes mellitus, with restrictive or obstructive
pulmonary disease, with high pulmonary artery pressure in preoperative
echocardiography and severe left ventricular failure, with ejection fraction
(EF) &#x0003c;30% in echocardiography, with preoperative cerebrovascular disease,
peripheral artery disease, renal insufficiency, patients receiving preoperative
inotropic or mechanical support, patients who would undergo redo surgery,
patients with inflammatory and rheumatic disease, and patients using
corticosteroids and antioxidants were excluded from the study. The patients&#x02019;
demographic data were recorded. Patients were randomly assigned to Group 1
(n=37), who were ventilated, and Group 2 (n=37), who were not ventilated, using
the sealed envelope technique.</p></sec><sec><title>Anesthesia Management</title><p>Standardized anesthesia management was performed according to the institutional
standardized protocol by the same anesthesiologist. Patients were monitored and
invasive catheterization to the radial artery was performed after intravenous
midazolam (Zolamid&#x000ae;, Defarma, Tekirdag, Turkey) (0.05-0.1 mg/kg) was
given. All patients were induced with fentanyl (Talinat&#x000ae;, Vem, Istanbul,
Turkey) (1-2 &#x000b5;g/kg) and pentothal (Pental&#x000ae; Sodium, Istanbul,
Turkey) (5-7 mg/kg); rocuronium bromide (Curon&#x000ae;, Mustafa Nevzat,
Istanbul, Turkey) (0.6 mg/kg, intravenously) was used to assist endotracheal
intubation. Sevoflurane (Sevorane&#x000ae;, Abbvie, Istanbul, Turkey) was used
with 50% oxygen and 50% air mixture for maintenance of anesthesia. A
Primus&#x000ae; (Draeger Medical, L&#x000fc;beck, Germany) anesthetic machine was
used for intraoperative mechanical ventilation. Surgery was started after
internal jugular vein catheterization. During the operation,
electrocardiography, arterial blood pressure, end-tidal carbon dioxide, pulse
oximetry, temperature, and urine output were monitored. Intravenous fentanyl
(3-5 &#x000b5;g/kg) was added before sternotomy. Heparin (300-400 units/kg) was
administered to achieve a clotting time &#x0003e;480 seconds before cannulation.
During total CPB, maintenance of anesthesia was achieved with midazolam,
fentanyl, and rocuronium.</p></sec><sec><title>Cardiopulmonary Bypass Management</title><p>Standard CPB was performed with mild hypothermia (32&#x000ba;C). After median sternotomy
and heparinization, CPB was performed with aorto-venous two-stage cannulation. A
cross-clamp was placed to the ascending aorta and cardiac arrest was provided
with cold antegrade cardioplegia with high potassium. Continuity of the cardiac
arrest was provided with blood cardioplegia given every 15-20 minutes. CPB was
established with a roller pump with a membrane oxygenator (Maquet, Getinge
group, Restalt, Germany) and arterial line filter at pump flow rates of 2-2.4
L/min/m<sup>2</sup>. Arterial blood gas was analyzed every 20-30 minutes.
Five hundred milliliters of hot blood cardioplegia was given just before the
cross-clamp was removed.</p></sec><sec><title>Ventilation Protocol</title><p>In Group 1, a ventilation strategy similar to the strategy used in the study of
Durukan et al.<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup> was used during total CPB. Patients were
ventilated with 5 mL/kg tidal volume, respiration rate, positive end expiratory
pressure (PEEP) 0, and fraction of inspired oxygen (FiO<sub>2</sub>) (50% air,
50% oxygen) 0.5. In Group 2, the endotracheal tube was opened to room air during
CPB and ventilation was discontinued. After the completion of the operation, all
patients were taken to the intensive care unit (ICU) and standard postoperative
care was performed. After the patients were awakened and hemodynamic stability
was obtained, extubation was performed with the routine procedure at the
earliest possible stage. Cross-clamp time, total bypass time, total anesthesia
time, number of anastomosis, length of ICU stay, and hospital stay days were
recorded.</p></sec><sec><title>Blood Sampling</title><p>Blood samples were taken from all patients in the preoperative period (T0), at
the 10<sup>th</sup> minute after total CPB (T1), and at the postoperative
6<sup>th</sup> (T2) and 24<sup>th</sup> hours (T3). Blood samples were
centrifuged at 3600 rpm for 10 min and serum plasma samples were removed and
stored at -80&#x000ba;C until analysis. Native thiol, total thiol, disulphide,
disulphide/native thiol ratio (SSSH), disulphide/total thiol percent ratio (SS
total SH), native thiol/total thiol percent ratio (SH total SH), and IMA levels
were studied.</p></sec><sec><title>Oxidation-Antioxidant Measurements</title><p>A new spectrophotometric technique used to establish thiol/disulphide homeostasis
was previously described by Erel and Neselioglu<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup>. IMA was studied
using the spectrophotometric method defined by Bar-Or et
al.<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup> and reported as absorption units.
Albumin-adjusted IMA was calculated according to the formula=[(&#x00131;ndividual
serum albumin concentration/median albumin concentration of the
population)&#x000d7;IMA value].<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup></p></sec><sec><title>Statistical Analysis</title><p>Statistical analyses were performed using the Statistical Package for the Social
Sciences software (IBM SPSS Statistic Inc., Chicago, IL, USA), version 21.0.
Continuous and ordinal variables were expressed as mean &#x000b1; standard
deviation and nominal variables were expressed as frequency and percentage. The
normality of the continuous variables was analyzed with Kolmogorov-Smirnov test
and Shapiro-Wilks test. Student&#x02019;s t-test was used to compare two groups for
continuous variables with normal distribution. Pearson&#x02019;s chi-squared test was
used to detect differences between groups on the basis of the categorical
variables. Mann-Whitney U test was performed to compare two groups for
continuous variables without normal distribution. To assess the relationship
between measurements of mean serum albumin, IMA, AAIMA, native-thiol, total
thiol, disulphide, SSSH, SS total SH, and SH total SH levels at different times,
the paired <italic>t</italic>-test and the Wilcoxon signed-rank test were used
in independent groups. A statistical significance was established when the
<italic>P</italic>-value was &#x0003c;0.05.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>Four hundred and six patients who underwent elective CABG were included in the study.
Forty-two patients with EF &#x0003c;30%, 25 with serum creatinine &#x0003e;2.0 mg/dL, 17 with
prior cardiac surgery, 15 using drugs that affected the antioxidant system, 76 with
diabetes mellitus, 55 with a history of smoking in the last five years, 18 who were
in need of undergoing bypass again, 21 who required intraoperative hemofiltration,
and 53 for other reasons were excluded from the study. Eighty-four patients were
included in the study; however, only 74 patients were included in the final
statistical evaluation because the serum of seven patients was hemolyzed, and three
patients&#x02019; serum samples were inadequate (<xref ref-type="fig" rid="f1">Figure
1</xref>). No significant difference was detected regarding demographic data
(<italic>P</italic>&#x0003e;0.05) (<xref rid="t1" ref-type="table">Table
1</xref>).</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Flow chart of the study. EF=ejection fraction</p></caption><graphic xlink:href="rbccv-34-04-0436-g01"/></fig>
</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Patients' demographic features.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="40%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Variable</th><th align="center" rowspan="1" colspan="1">Group 1 (n=37)</th><th align="center" rowspan="1" colspan="1">Group 2 (n=37)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age, years (mean&#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">61.14&#x000b1;9.49</td><td align="center" rowspan="1" colspan="1">61.11&#x000b1;9.03</td><td align="center" rowspan="1" colspan="1">0.990</td></tr><tr><td align="left" rowspan="1" colspan="1">Male gender, n (%)</td><td align="center" rowspan="1" colspan="1">28 (75.7)</td><td align="center" rowspan="1" colspan="1">32 (86.5)</td><td align="center" rowspan="1" colspan="1">0.187 </td></tr><tr><td align="left" rowspan="1" colspan="1">ASA III/IV, n</td><td align="center" rowspan="1" colspan="1">16/21</td><td align="center" rowspan="1" colspan="1">13/24</td><td align="center" rowspan="1" colspan="1">0.317 </td></tr><tr><td align="left" rowspan="1" colspan="1">EuroSCORE</td><td align="center" rowspan="1" colspan="1">4.41&#x000b1;1.77</td><td align="center" rowspan="1" colspan="1">4.46&#x000b1;1.77</td><td align="center" rowspan="1" colspan="1">0.903</td></tr><tr><td align="left" rowspan="1" colspan="1">BSA</td><td align="center" rowspan="1" colspan="1">1.89&#x000b1;0.15</td><td align="center" rowspan="1" colspan="1">1.89&#x000b1;0.19</td><td align="center" rowspan="1" colspan="1">0.834</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypertension, n (%)</td><td align="center" rowspan="1" colspan="1">22 (59.5)</td><td align="center" rowspan="1" colspan="1">28 (75.7)</td><td align="center" rowspan="1" colspan="1">0.214 </td></tr><tr><td align="left" rowspan="1" colspan="1">EF, % (mean&#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">51.92&#x000b1;9.29</td><td align="center" rowspan="1" colspan="1">50.68&#x000b1;8.18</td><td align="center" rowspan="1" colspan="1">0.543 </td></tr><tr><td align="left" rowspan="1" colspan="1">Cross-clamp time, min (mean&#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">71.35&#x000b1;31.29</td><td align="center" rowspan="1" colspan="1">66.54&#x000b1;19.55</td><td align="center" rowspan="1" colspan="1">0.837 </td></tr><tr><td align="left" rowspan="1" colspan="1">Cardiopulmonary bypass time, min (mean&#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">99.49&#x000b1;37.26</td><td align="center" rowspan="1" colspan="1">96.19&#x000b1;26.27</td><td align="center" rowspan="1" colspan="1">0.846 </td></tr><tr><td align="left" rowspan="1" colspan="1">Total anesthesia time, min (mean&#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">269.54&#x000b1;54.63</td><td align="center" rowspan="1" colspan="1">247.57&#x000b1;39.72</td><td align="center" rowspan="1" colspan="1">0.052 </td></tr><tr><td align="left" rowspan="1" colspan="1">Number of anastomoses</td><td align="center" rowspan="1" colspan="1">3.03&#x000b1;1.36</td><td align="center" rowspan="1" colspan="1">3.38&#x000b1;0.86</td><td align="center" rowspan="1" colspan="1">0.189</td></tr><tr><td align="left" rowspan="1" colspan="1">Number of erythrocytes</td><td align="center" rowspan="1" colspan="1">2.54&#x000b1;1.28</td><td align="center" rowspan="1" colspan="1">2.35&#x000b1;0.92</td><td align="center" rowspan="1" colspan="1">0.468</td></tr><tr><td align="left" rowspan="1" colspan="1">Number of plasma</td><td align="center" rowspan="1" colspan="1">3.84&#x000b1;1.17</td><td align="center" rowspan="1" colspan="1">3.76&#x000b1;1.28</td><td align="center" rowspan="1" colspan="1">0.776</td></tr><tr><td align="left" rowspan="1" colspan="1">ICU stay, days (mean&#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">2.27&#x000b1;0.69</td><td align="center" rowspan="1" colspan="1">2.22&#x000b1;0.42</td><td align="center" rowspan="1" colspan="1">0.686</td></tr><tr><td align="left" rowspan="1" colspan="1">Hospital stay, days (mean&#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">5.16&#x000b1;2.27</td><td align="center" rowspan="1" colspan="1">6.89&#x000b1;0.57</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001<sup><xref ref-type="table-fn" rid="TFN3">#</xref></sup></td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>ASA=American Society of Anesthesiologists' physical status
classification; BSA=body surface area; EF=ejection fraction;
EuroSCORE=European System for Cardiac Operative Risk Evaluation;
ICU=&#x00131;ntensive care unit; SD=standard deviation</p></fn><fn id="TFN2"><p>Group 1=Continuous ventilation group; Group 2=Nonventilated group;</p></fn><fn id="TFN3"><label>#</label><p>Mann-Whitney U test</p></fn></table-wrap-foot></table-wrap><p>In the comparisons between the groups, no differences were found in terms of T0, T1,
and T2&#x02019;s native thiol, total thiol, disulphide, SSSH, SS total SH, SH total SH, IMA,
and AAIMA levels (<italic>P</italic>&#x0003e;0.05, <xref rid="t2" ref-type="table">Table
2</xref>). There were statistically significant differences between the groups
in terms of native thiol, total thiol, and IMA levels at the postoperative
24<sup>th</sup> hour (respectively, <italic>P</italic>=0.030,
<italic>P</italic>=0.031, and <italic>P</italic>=0.004) (<xref rid="t2" ref-type="table">Table 2</xref>).</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Thiol/disulphide homeostasis, ischemia-modified albumin levels, and
albumin-adjusted ischemia-modified albumin.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="40%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Parameters</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">T0</th><th align="center" rowspan="1" colspan="1">T1</th><th align="center" rowspan="1" colspan="1">T2</th><th align="center" rowspan="1" colspan="1">T3</th><th align="center" rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead><tbody><tr><td align="left" rowspan="3" colspan="1">Native thiol (&#x000b5;mol/L)</td><td align="center" rowspan="1" colspan="1">Group I (<italic>n</italic>=37)</td><td align="center" rowspan="1" colspan="1">181.23&#x000b1;48.33</td><td align="center" rowspan="1" colspan="1">84.14&#x000b1;44.55</td><td align="center" rowspan="1" colspan="1">202.31&#x000b1;49.98</td><td align="center" rowspan="1" colspan="1">245.24&#x000b1;57.45</td><td align="center" rowspan="1" colspan="1">T0-T1 &#x0003c;0.001<xref ref-type="table-fn" rid="TFN9">&#x000b6;</xref><break/>T0-T2 0.357<break/>T0-T3 &#x0003c;0.001</td></tr><tr><td align="center" rowspan="1" colspan="1">Group II (<italic>n</italic>=37)</td><td align="center" rowspan="1" colspan="1">178.78&#x000b1;41.06</td><td align="center" rowspan="1" colspan="1">99.67&#x000b1;50.24</td><td align="center" rowspan="1" colspan="1">194.94&#x000b1;43.73</td><td align="center" rowspan="1" colspan="1">219.44&#x000b1;41.52</td><td align="center" rowspan="1" colspan="1">T0-T1 &#x0003c;0.001<xref ref-type="table-fn" rid="TFN9">&#x000b6;</xref><break/>T0-T2 0.055<break/>T0-T3 &#x0003c;0.001<xref ref-type="table-fn" rid="TFN9">&#x000b6;</xref></td></tr><tr><td align="center" rowspan="1" colspan="1"><italic>P</italic></td><td align="center" rowspan="1" colspan="1">0.815</td><td align="center" rowspan="1" colspan="1">0.155 </td><td align="center" rowspan="1" colspan="1">0.502</td><td align="center" rowspan="1" colspan="1">0.030<xref ref-type="table-fn" rid="TFN7">*</xref></td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="3" colspan="1">Total thiol (&#x000b5;mol/L)</td><td align="center" rowspan="1" colspan="1">Group I (<italic>n</italic>=37)</td><td align="center" rowspan="1" colspan="1">205.73&#x000b1;52.76</td><td align="center" rowspan="1" colspan="1">102.97&#x000b1;44.55</td><td align="center" rowspan="1" colspan="1">230.68&#x000b1;51.22</td><td align="center" rowspan="1" colspan="1">269.85&#x000b1;57.81</td><td align="center" rowspan="1" colspan="1">T0-T1 &#x0003c;0.001<xref ref-type="table-fn" rid="TFN9">&#x000b6;</xref><break/>T0-T2 0.027<xref ref-type="table-fn" rid="TFN9">&#x000b6;</xref><break/>T0-T3 &#x0003c;0.001<xref ref-type="table-fn" rid="TFN9">&#x000b6;</xref></td></tr><tr><td align="center" rowspan="1" colspan="1">Group II (<italic>n</italic>=37)</td><td align="center" rowspan="1" colspan="1">206.45&#x000b1;46.94</td><td align="center" rowspan="1" colspan="1">119.48 &#x000b1;53.20</td><td align="center" rowspan="1" colspan="1">220.86&#x000b1;45.41</td><td align="center" rowspan="1" colspan="1">243.53&#x000b1;43.89</td><td align="center" rowspan="1" colspan="1">T0-T1 &#x0003c;0.001<xref ref-type="table-fn" rid="TFN9">&#x000b6;</xref><break/>T0-T2 0.099<break/>T0-T3 &#x0003c;0.001<xref ref-type="table-fn" rid="TFN9">&#x000b6;</xref></td></tr><tr><td align="center" rowspan="1" colspan="1"><italic>P</italic></td><td align="center" rowspan="1" colspan="1">0.951</td><td align="center" rowspan="1" colspan="1">0.178</td><td align="center" rowspan="1" colspan="1">0.386</td><td align="center" rowspan="1" colspan="1">0.031<xref ref-type="table-fn" rid="TFN7">*</xref></td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="3" colspan="1">Disulphide (&#x000b5;mol/L)</td><td align="center" rowspan="1" colspan="1">Group I (<italic>n</italic>=37)</td><td align="center" rowspan="1" colspan="1">12.75&#x000b1;6.13</td><td align="center" rowspan="1" colspan="1">9.41&#x000b1;4.44</td><td align="center" rowspan="1" colspan="1">14.18&#x000b1;5.47</td><td align="center" rowspan="1" colspan="1">12.31&#x000b1;3.69</td><td align="center" rowspan="1" colspan="1">T0-T1 0.012<xref ref-type="table-fn" rid="TFN9">&#x000b6;</xref><break/>T0-T2 0.210<break/>T0-T3 0.662</td></tr><tr><td align="center" rowspan="1" colspan="1">Group II (<italic>n</italic>=37)</td><td align="center" rowspan="1" colspan="1">13.82&#x000b1;4.91</td><td align="center" rowspan="1" colspan="1">9.90&#x000b1;3.44</td><td align="center" rowspan="1" colspan="1">12.96&#x000b1;5.27</td><td align="center" rowspan="1" colspan="1">11.91&#x000b1;4.15</td><td align="center" rowspan="1" colspan="1">T0-T1 &#x0003c;0.001<xref ref-type="table-fn" rid="TFN9">&#x000b6;</xref><break/>T0-T2 0.414<break/>T0-T3 0.053</td></tr><tr><td align="center" rowspan="1" colspan="1"><italic>P</italic></td><td align="center" rowspan="1" colspan="1">0.410</td><td align="center" rowspan="1" colspan="1">0.599</td><td align="center" rowspan="1" colspan="1">0.331</td><td align="center" rowspan="1" colspan="1">0.664</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="3" colspan="1">Disulphide/native thiol ratio ' 100</td><td align="center" rowspan="1" colspan="1">Group I (<italic>n</italic>=37)</td><td align="center" rowspan="1" colspan="1">7.62&#x000b1;4.80</td><td align="center" rowspan="1" colspan="1">15.48&#x000b1;12.96</td><td align="center" rowspan="1" colspan="1">7.80&#x000b1;4.87</td><td align="center" rowspan="1" colspan="1">5.38&#x000b1;2.29</td><td align="center" rowspan="1" colspan="1">T0-T1 &#x0003c;0.001<xref ref-type="table-fn" rid="TFN9">&#x000b6;</xref><break/>T0-T2 0.866<break/>T0-T3 0.011<xref ref-type="table-fn" rid="TFN9">&#x000b6;</xref></td></tr><tr><td align="center" rowspan="1" colspan="1">Group II (<italic>n</italic>=37)</td><td align="center" rowspan="1" colspan="1">7.83&#x000b1;2.59</td><td align="center" rowspan="1" colspan="1">11.95&#x000b1;5.95</td><td align="center" rowspan="1" colspan="1">6.97&#x000b1;3.30</td><td align="center" rowspan="1" colspan="1">5.59&#x000b1;2.15</td><td align="center" rowspan="1" colspan="1">T0-T1 &#x0003c;0.001<xref ref-type="table-fn" rid="TFN9">&#x000b6;</xref><break/>T0-T2 0.217<break/>T0-T3 &#x0003c;0.001<xref ref-type="table-fn" rid="TFN9">&#x000b6;</xref></td></tr><tr><td align="center" rowspan="1" colspan="1"><italic>P</italic></td><td align="center" rowspan="1" colspan="1">0.317</td><td align="center" rowspan="1" colspan="1">0.140</td><td align="center" rowspan="1" colspan="1">0.492</td><td align="center" rowspan="1" colspan="1">0.492</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="3" colspan="1">Disulphide/total thiol ratio ' 100</td><td align="center" rowspan="1" colspan="1">Group I (<italic>n</italic>=37)</td><td align="center" rowspan="1" colspan="1">6.33&#x000b1;3.27</td><td align="center" rowspan="1" colspan="1">10.54&#x000b1;5.90</td><td align="center" rowspan="1" colspan="1">6.48&#x000b1;3.17</td><td align="center" rowspan="1" colspan="1">4.77&#x000b1;1.79</td><td align="center" rowspan="1" colspan="1">T0-T1 &#x0003c;0.001<xref ref-type="table-fn" rid="TFN9">&#x000b6;</xref><break/>T0-T2 0.832<break/>T0-T3 0.010<xref ref-type="table-fn" rid="TFN9">&#x000b6;</xref></td></tr><tr><td align="center" rowspan="1" colspan="1">Group II (<italic>n</italic>=37)</td><td align="center" rowspan="1" colspan="1">6.68&#x000b1;1.95</td><td align="center" rowspan="1" colspan="1">9.30&#x000b1;3.60</td><td align="center" rowspan="1" colspan="1">5.97&#x000b1;2.45</td><td align="center" rowspan="1" colspan="1">4.96&#x000b1;1.65</td><td align="center" rowspan="1" colspan="1">T0-T1 &#x0003c;0.001<xref ref-type="table-fn" rid="TFN9">&#x000b6;</xref><break/>T0-T2 0.180<break/>T0-T3 &#x0003c;0.001<xref ref-type="table-fn" rid="TFN9">&#x000b6;</xref></td></tr><tr><td align="center" rowspan="1" colspan="1"><italic>P</italic></td><td align="center" rowspan="1" colspan="1">0.302</td><td align="center" rowspan="1" colspan="1">0.338</td><td align="center" rowspan="1" colspan="1">0.520</td><td align="center" rowspan="1" colspan="1">0.641</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="3" colspan="1">Native thiol/total thiol ratio ' 100</td><td align="center" rowspan="1" colspan="1">Group I (<italic>n</italic>=37)</td><td align="center" rowspan="1" colspan="1">87.47&#x000b1;6.49</td><td align="center" rowspan="1" colspan="1">78.76&#x000b1;11.85</td><td align="center" rowspan="1" colspan="1">87.04&#x000b1;6.34</td><td align="center" rowspan="1" colspan="1">90.45&#x000b1;3.59</td><td align="center" rowspan="1" colspan="1">T0-T1 &#x0003c;0.001<xref ref-type="table-fn" rid="TFN9">&#x000b6;</xref><break/>T0-T2 0.757<break/>T0-T3 0.013<xref ref-type="table-fn" rid="TFN9">&#x000b6;</xref></td></tr><tr><td align="center" rowspan="1" colspan="1">Group II (<italic>n</italic>=37)</td><td align="center" rowspan="1" colspan="1">88.63&#x000b1;3.90</td><td align="center" rowspan="1" colspan="1">81.42&#x000b1;7.19</td><td align="center" rowspan="1" colspan="1">87.99&#x000b1;4.92</td><td align="center" rowspan="1" colspan="1">90.06&#x000b1;3.30</td><td align="center" rowspan="1" colspan="1">T0-T1 &#x0003c;0.001<xref ref-type="table-fn" rid="TFN9">&#x000b6;</xref><break/>T0-T2 0.194<break/>T0-T3 &#x0003c;0.001<xref ref-type="table-fn" rid="TFN9">&#x000b6;</xref></td></tr><tr><td align="center" rowspan="1" colspan="1"><italic>P</italic></td><td align="center" rowspan="1" colspan="1">0.504</td><td align="center" rowspan="1" colspan="1">0.246</td><td align="center" rowspan="1" colspan="1">0.470</td><td align="center" rowspan="1" colspan="1">0.446</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="3" colspan="1">IMA (ABSU)</td><td align="center" rowspan="1" colspan="1">Group I (<italic>n</italic>=37)</td><td align="center" rowspan="1" colspan="1">0.69&#x000b1;0.13</td><td align="center" rowspan="1" colspan="1">1.07&#x000b1;0.14</td><td align="center" rowspan="1" colspan="1">0.77&#x000b1;0.15</td><td align="center" rowspan="1" colspan="1">0.77&#x000b1;0.12</td><td align="center" rowspan="1" colspan="1">T0-T1 &#x0003c;0.000<xref ref-type="table-fn" rid="TFN9">&#x000b6;</xref><break/>T0-T2 0.008<xref ref-type="table-fn" rid="TFN9">&#x000b6;</xref><break/>T0-T3 0.007<xref ref-type="table-fn" rid="TFN9">&#x000b6;</xref></td></tr><tr><td align="center" rowspan="1" colspan="1">Group II (<italic>n</italic>=37)</td><td align="center" rowspan="1" colspan="1">0.73&#x000b1;0.12</td><td align="center" rowspan="1" colspan="1">1.00&#x000b1;0.16</td><td align="center" rowspan="1" colspan="1">0.77&#x000b1;0.10</td><td align="center" rowspan="1" colspan="1">0.82&#x000b1;0.09</td><td align="center" rowspan="1" colspan="1">T0-T1 &#x0003c;0.001<xref ref-type="table-fn" rid="TFN9">&#x000b6;</xref><break/>T0-T2 0.089<break/>T0-T3 &#x0003c;0.001<xref ref-type="table-fn" rid="TFN9">&#x000b6;</xref></td></tr><tr><td align="center" rowspan="1" colspan="1"><italic>P</italic></td><td align="center" rowspan="1" colspan="1">0.052</td><td align="center" rowspan="1" colspan="1">0.112</td><td align="center" rowspan="1" colspan="1">0.961</td><td align="center" rowspan="1" colspan="1">0.004<sup><xref ref-type="table-fn" rid="TFN6">#</xref></sup></td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="3" colspan="1">Albumin</td><td align="center" rowspan="1" colspan="1">Group I (<italic>n</italic>=37)</td><td align="center" rowspan="1" colspan="1">3.28&#x000b1;0.38</td><td align="center" rowspan="1" colspan="1">1.41&#x000b1;0.72</td><td align="center" rowspan="1" colspan="1">2.96&#x000b1;0.77</td><td align="center" rowspan="1" colspan="1">3.01&#x000b1;0.10</td><td align="center" rowspan="1" colspan="1">T0-T1 &#x0003c;0.001<xref ref-type="table-fn" rid="TFN8">&#x000b5;</xref><break/>T0-T2 &#x0003c;0.029<xref ref-type="table-fn" rid="TFN8">&#x000b5;</xref><break/>T0-T3 0.014<xref ref-type="table-fn" rid="TFN8">&#x000b5;</xref></td></tr><tr><td align="center" rowspan="1" colspan="1">Group II (<italic>n</italic>=37)</td><td align="center" rowspan="1" colspan="1">3.1&#x000b1;0.57</td><td align="center" rowspan="1" colspan="1">1.81&#x000b1;1.00</td><td align="center" rowspan="1" colspan="1">3.10&#x000b1;0.42</td><td align="center" rowspan="1" colspan="1">2.68&#x000b1;0.82</td><td align="center" rowspan="1" colspan="1">T0-T1 &#x0003c;0.001<xref ref-type="table-fn" rid="TFN8">&#x000b5;</xref><break/>T0-T2 0.698<break/>T0-T3 0.013<xref ref-type="table-fn" rid="TFN8">&#x000b5;</xref></td></tr><tr><td align="center" rowspan="1" colspan="1"><italic>P</italic></td><td align="center" rowspan="1" colspan="1">0.182</td><td align="center" rowspan="1" colspan="1">0.095</td><td align="center" rowspan="1" colspan="1">0.910</td><td align="center" rowspan="1" colspan="1">0.079</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="3" colspan="1">AAIMA</td><td align="center" rowspan="1" colspan="1">Group I (<italic>n</italic>=37)</td><td align="center" rowspan="1" colspan="1">0.68&#x000b1;0.12</td><td align="center" rowspan="1" colspan="1">0.97&#x000b1;0.38</td><td align="center" rowspan="1" colspan="1">0.68&#x000b1;0.15</td><td align="center" rowspan="1" colspan="1">0.71&#x000b1;0.10</td><td align="center" rowspan="1" colspan="1">T0-T1 &#x0003c;0.001<xref ref-type="table-fn" rid="TFN9">&#x000b6;</xref><break/>T0-T2 0.897<break/>T0-T3 0.412</td></tr><tr><td align="center" rowspan="1" colspan="1">Group II (<italic>n</italic>=37)</td><td align="center" rowspan="1" colspan="1">0.69&#x000b1;0.08</td><td align="center" rowspan="1" colspan="1">1.15&#x000b1;1.51</td><td align="center" rowspan="1" colspan="1">0.73&#x000b1;0.06</td><td align="center" rowspan="1" colspan="1">0.68 &#x000b1;0.17</td><td align="center" rowspan="1" colspan="1">T0-T1 &#x0003c;0.001<xref ref-type="table-fn" rid="TFN9">&#x000b6;</xref><break/>T0-T2 0.014<xref ref-type="table-fn" rid="TFN9">&#x000b6;</xref><break/>T0-T3 0.788</td></tr><tr><td align="center" rowspan="1" colspan="1"><italic>P</italic></td><td align="center" rowspan="1" colspan="1">0.204</td><td align="center" rowspan="1" colspan="1">0.143</td><td align="center" rowspan="1" colspan="1">0.336</td><td align="center" rowspan="1" colspan="1">0.534</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr></tbody></table><table-wrap-foot><fn id="TFN4"><p>AAIMA=albumin-adjusted ischemia-modified albumin; ABSU=absorbance units;
IMA=&#x00131;schemia-modified albumin</p></fn><fn id="TFN5"><p>Data presented show values at the moment of T0=preoperatively; T1=at the
10th minute after total cardiopulmonary bypass; T2=postoperative 6th
hour; and T3=postoperative 24th hour. Group 1=Continuous ventilation
group, Group 2=Nonventilated group. A <italic>P</italic>-value of
&#x0003c;0.05 is statistically significant.</p></fn><fn id="TFN6"><label>#</label><p>Mann-Whitney U test;</p></fn><fn id="TFN7"><label>*</label><p>Student's t-test;</p></fn><fn id="TFN8"><label>&#x000b5;</label><p>Wilcoxon signed-rank test;</p></fn><fn id="TFN9"><label>&#x000b6;</label><p>Paired sample test</p></fn></table-wrap-foot></table-wrap><p>In the comparison of T0 and T1 between each group, there were statistically
significant differences in terms of serum native thiol, total thiol, disulphide,
SSSH, SS total SH, SH total SH, IMA, and AAIMA levels in both groups (<xref rid="t2" ref-type="table">Table 2</xref>).</p><p>In the comparison between T0 and T2 in Group 1, serum total thiol and albumin levels
were significantly lower (<italic>P</italic>=0.027 and <italic>P</italic>=0.029,
respectively) and IMA levels were higher (<italic>P</italic>=0.008) than in other
groups. In the comparison between T0 and T2 in Group 1, there was no difference in
terms of serum native thiol, disulphide, SSSH, SS total SH, SH total SH, and AAIMA
(<italic>P</italic>&#x0003e;0.05). In the comparison between T0 and T3 in Group 1,
serum native thiol, total thiol, SH total SH, and IMA levels were statistically
significantly higher (<italic>P</italic>&#x0003c;0.001, <italic>P</italic>&#x0003c;0.001,
<italic>P</italic>=0.013, and <italic>P</italic>=0.007, respectively) and SSSH
and SS total SH levels were lower (<italic>P</italic>=0.011 and
<italic>P</italic>=0.010, respectively) than in other groups. There was no
difference between T0 and T3 in Group 1 in terms of disulphide and AAIMA levels
(<italic>P</italic>&#x0003e;0.05).</p><p>There was a statistically significant increase in levels of AAIMA between T0 and T2
in Group 2 (<italic>P</italic>=0.014). In the comparison between T0 and T2 in Group
2, there was no difference in terms of serum native thiol, total thiol, disulphide,
SSSH, SS total SH, SH total SH, and IMA (<italic>P</italic>&#x0003e;0.05). In the
comparison between T0 and T3 in Group 2, serum native thiol, total thiol, SH total
SH, and IMA levels were statistically significantly higher
(<italic>P</italic>&#x0003c;0.001) and SSSH and SS total SH levels were lower
(<italic>P</italic>&#x0003c;0.001) than in other groups. There was no difference
between T0 and T3 in Group 2 in terms of disulphide and AAIMA levels
(<italic>P</italic>&#x0003e;0.05).</p><p>Albumin levels were similar between the groups (<italic>P</italic>&#x0003e;0.05). In
T0-T1, T0-T2, and T0-T3 comparisons between each group in terms of albumin, a
significant decrease in Group 1 was detected (<italic>P</italic>&#x0003c;0.001,
<italic>P</italic>=0.029, and <italic>P</italic>=0.014, respectively). The
change in albumin level was statistically significant in Group 2 in T0-T1 and T0-T3
comparisons (<italic>P</italic>&#x0003c;0.001 and <italic>P</italic>=0.013,
respectively). There was no difference between the groups in terms of length of stay
in the ICU (<xref rid="t1" ref-type="table">Table 1</xref>)
(<italic>P</italic>&#x0003e;0.05). Duration of hospitalization was significantly lower in
Group 1 than in Group 2 (<xref rid="t1" ref-type="table">Table 1</xref>)
<italic>(P</italic>&#x0003c;0.001).</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>To the best of our knowledge, our study is the first to investigate the effect of
continuous ventilation during CPB on thiol/disulphide homeostasis and IMA. In
patients who were ventilated, native thiol and total thiol values were significantly
higher at the postoperative 24<sup>th</sup> hour than in patients who were not
ventilated. Although IMA levels were higher at the postoperative 24<sup>th</sup>
hour in patients who were not ventilated than in those who were, there was no
difference in terms of AAIMA levels. AAIMA levels returned to start levels at the
6<sup>th</sup> postoperative hour in patients who were ventilated and at the
24<sup>th</sup> postoperative hour in patients who were not ventilated. Also,
the duration of hospitalization was significantly shorter in patients who were
ventilated than in patients who were not ventilated.</p><p>It is known that CABG surgery increases oxidative parameters and produces a strong
antioxidant response<sup>[<xref rid="r1" ref-type="bibr">1</xref>-<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r6" ref-type="bibr">6</xref>,<xref rid="r19" ref-type="bibr">19</xref>]</sup>. Antioxidant capacity is seen as a predictive
parameter in determining postoperative complications<sup>[<xref rid="r20" ref-type="bibr">20</xref>]</sup>. IMA is believed to be
triggered by a decrease in blood flow. Various studies in the literature have
investigated the effects of off-pump CABG surgery, different CPB membrane systems,
the use of perioperative antioxidant supplements, and pulmonary functions on the
oxidative system<sup>[<xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r10" ref-type="bibr">10</xref>,<xref rid="r20" ref-type="bibr">20</xref>]</sup>. There are also studies investigating the effects
of perioperative mechanical ventilation strategies on inflammation in
CABG<sup>[<xref rid="r16" ref-type="bibr">16</xref>,<xref rid="r21" ref-type="bibr">21</xref>,<xref rid="r22" ref-type="bibr">22</xref>]</sup>. Although there are studies on oxidative parameters
in CABG<sup>[<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r8" ref-type="bibr">8</xref>]</sup>, there are few studies on IMA<sup>[<xref rid="r6" ref-type="bibr">6</xref>,<xref rid="r19" ref-type="bibr">19</xref>]</sup> and no studies on
thiol/disulphide homeostasis.</p><p>Alt&#x00131;parmak et al.<sup>[<xref rid="r23" ref-type="bibr">23</xref>]</sup> showed low native thiol levels in patients with
coronary artery disease (CAD) with critical stenosis who underwent coronary
angiography. They demonstrated lower disulphide levels in patients with stenosis
than in those without stenosis and showed that the decrease in thiols was an
important indicator for CAD formation. Kundi et al.<sup>[<xref rid="r24" ref-type="bibr">24</xref>]</sup> found out that native
thiol, total thiol, and disulphide levels were lower and SS total SH was higher in
patients who had acute myocardial infarction. To our knowledge, our study is the
first to investigate the effect of continuous ventilation during CPB on
thiol/disulphide homeostasis. Similarly to Kundi et al.<sup>[<xref rid="r24" ref-type="bibr">24</xref>]</sup>, we found out that the
effect on native thiol and total thiol was more prominent in Group 2. We found out
that disulphide levels were low in each group, except at the postoperative
6<sup>th</sup> hour in Group 2, but there was no difference between the groups
in terms of disulphide levels. In our study, especially just after CPB, native
thiol, total thiol, disulphide, SH total SH, and albumin levels were significantly
lower in all patients, whereas SSSH and SS total SH did not change. Native thiol and
total thiol levels at T3 were higher in patients who were ventilated than in
patients who were not. Native thiol and total thiol levels at T2 were higher
compared with the preoperative levels in the group that was ventilated. At the
postoperative 24<sup>th</sup> hour, thiol/disulphide homeostasis measures did not
reach baseline levels, except for disulphide levels.</p><p>Decreased blood flow may induce reactive oxygen species and, consequently, they may
modify the N-terminal portion of albumin causing an increased formation of IMA. IMA
is helpful in establishing diagnosis in the early stages of ischemia, before
necrosis develops<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup>. The free radical binding capacity of IMA is very
low. Elevation of IMA is directly associated with free radicals that form during
ischemia<sup>[<xref rid="r25" ref-type="bibr">25</xref>]</sup>.</p><p>Kanko et al.<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup> measured IMA levels at the 30<sup>th</sup> minute
of cross-clamping and at the 6<sup>th</sup> postoperative hour in 30 patients who
underwent CABG. The highest IMA value was found in the intraoperative period and
although IMA values decreased at the postoperative 6<sup>th</sup> hour, they did not
reach the initial level<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup>. Thielman et al.<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup> investigated IMA as a
diagnostic marker of myocardial injury (MI) in patients who underwent CABG. They
showed that the diagnostic value of IMA was limited and IMA values were measured as
high until the postoperative 72<sup>nd</sup> hour<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>. We found out that the
IMA value was the highest in the post-pump intraoperative period, as with Kanko et
al.<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup>,
and that the IMA value did not reach the initial level at the postoperative 24th
hour. In patients who undergo CPB in CABG, the IMA level may be misleading because
the change in the albumin value is high; the AAIMA level may be more accurate.
Therefore, we looked at the values of AAIMA, different from other studies, but we
found no difference between the groups. In addition, the AAIMA level reached the
initial level at the postoperative 6th hour in patients who were ventilated but it
took until the postoperative 24<sup>th</sup> hour in patients who were not
ventilated.</p><p>Luyten et al.<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup> focused on oxidative products induced by I/R in
cardiac surgery. They measured antioxidant capacity, glutathione peroxidase, and
superoxide dismutase after starting CPB, 10 minutes after CPB was finished, and at
the postoperative 4<sup>th</sup> and 24<sup>th</sup> hours in 10 patients who
underwent CABG and found an increase in those levels in the intraoperative
period.</p><p>Continuous lung ventilation during CPB can reduce ischemia and lung damage by
reducing the drop in blood flow to the bronchial artery<sup>[<xref rid="r11" ref-type="bibr">11</xref>,<xref rid="r13" ref-type="bibr">13</xref>-<xref rid="r15" ref-type="bibr">15</xref>]</sup>. In the literature,
there are studies showing less postoperative pulmonary complications, pulmonary
edema, and lung damage<sup>[<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r12" ref-type="bibr">12</xref>,<xref rid="r13" ref-type="bibr">13</xref>,<xref rid="r22" ref-type="bibr">22</xref>]</sup>, decreased inflammation<sup>[<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r22" ref-type="bibr">22</xref>]</sup>, better postoperative
pulmonary compliance and oxygenation<sup>[<xref rid="r12" ref-type="bibr">12</xref>,<xref rid="r14" ref-type="bibr">14</xref>,<xref rid="r21" ref-type="bibr">21</xref>]</sup>, and shorter extubation time<sup>[<xref rid="r14" ref-type="bibr">14</xref>]</sup> related to ventilation
strategy. Fernando et al.<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup> showed in their review that lung protective
methods, such as ventilation with lower tidal volumes and higher PEEP, decreased
postoperative pulmonary complications and inflammation; however, they concluded that
strong, randomized, and controlled studies were needed. John et
al.<sup>[<xref rid="r13" ref-type="bibr">13</xref>]</sup> showed that continuous ventilation with 5 mL/kg
tidal volume during CABG presented less extravascular lung water, lung damage, and a
shorter extubation time than without it. We also investigated the relationship
between low tidal volume lung ventilation and length of ICU and hospital stay. In
our study, we performed ventilation five times per minute with 5 mL low tidal volume
without PEEP and found out that there was no difference between the groups in terms
of length of ICU stay, but patients who were ventilated stayed in hospital for
significantly less time than patients who were not ventilated. Durukan et
al.<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup>
used a low ventilation strategy, similarly to us, and found no difference in terms
of extubation time and duration of hospital stay. In studies using continuous
ventilation in CPB, no change in duration of hospital stay was
found<sup>[<xref rid="r12" ref-type="bibr">12</xref>,<xref rid="r15" ref-type="bibr">15</xref>]</sup>.</p><p>Interruption of ventilation during CABG is one of the causes of lung injury in
cardiac surgery. The lungs are very sensitive to the systemic inflammatory response
effect due to CABG and I/R<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>. Setting different respiratory parameters in CABG
surgery may positively affect clinical outcomes<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>. It is easy to
continue ventilation during total CPB in CABG. This had a positive effect on native
thiol, total thiol, and AAIMA levels in the postoperative period, and decreased the
duration of hospital stay.</p><sec><title>Study Limitations</title><p>There are some limitations in this study. This was a single-center study. No cost
measurement was performed. No inflammatory markers were measured. Postoperative
pulmonary complications were not recorded. Long-term postoperative antioxidant
status was not studied, and the postoperative extubation time was not
recorded.</p></sec></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>CABG causes I/R damage and an increase in oxidation parameters that will affect the
heart, lungs, and all cells. Continuous ventilation during CBP caused an increase in
levels of native and total thiols at the postoperative 24th hour, early return of
AAIMA levels to their initial preoperative levels, and short hospital stay.
Accordingly, continuous ventilation can reduce the negative effects of CPB on the
myocardium. There is a need for further studies in which different ventilation
strategies should be compared and patients should be followed up for longer
periods.</p><table-wrap id="t4" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="95%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Author's roles &#x00026; responsibilities</th></tr></thead><tbody><tr align="left"><td valign="top" rowspan="1" colspan="1">SEO</td><td valign="top" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or the acquisition, analysis, or interpretation of data
for the work; drafting the work or revising it critically for
important intellectual content; agreement to be accountable for all
aspects of the work in ensuring that questions related to the
accuracy or integrity of any part of the work are appropriately
investigated and resolved; final approval of the version to be
published</td></tr><tr align="left"><td valign="top" rowspan="1" colspan="1">KKO</td><td valign="top" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or the acquisition, analysis, or interpretation of data
for the work; drafting the work or revising it critically for
important intellectual content; agreement to be accountable for all
aspects of the work in ensuring that questions related to the
accuracy or integrity of any part of the work are appropriately
investigated and resolved; final approval of the version to be
published</td></tr><tr align="left"><td valign="top" rowspan="1" colspan="1">YU</td><td valign="top" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or the acquisition, analysis, or interpretation of data
for the work; final approval of the version to be published</td></tr><tr align="left"><td valign="top" rowspan="1" colspan="1">DK</td><td valign="top" rowspan="1" colspan="1">Drafting the work or revising it critically for
important intellectual content; final approval of the version to be
published</td></tr><tr align="left"><td valign="top" rowspan="1" colspan="1">BO</td><td valign="top" rowspan="1" colspan="1">Drafting the work or revising it critically for
important intellectual content; final approval of the version to be
published</td></tr><tr align="left"><td valign="top" rowspan="1" colspan="1">BB</td><td valign="top" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or the acquisition, analysis, or interpretation of data
for the work; final approval of the version to be published</td></tr><tr align="left"><td valign="top" rowspan="1" colspan="1">OE</td><td valign="top" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or the acquisition, analysis, or interpretation of data
for the work; final approval of the version to be published</td></tr><tr align="left"><td valign="top" rowspan="1" colspan="1">SY</td><td valign="top" rowspan="1" colspan="1">Drafting the work or revising it critically for
important intellectual content; final approval of the version to be
published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out at Department of Cardiovascular Surgery, University of
Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital, Bursa,
Turkey.</p></fn><fn fn-type="financial-disclosure"><p>No financial support.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hatemi</surname><given-names>AC</given-names></name><name><surname>&#x000c7;eviker</surname><given-names>K</given-names></name><name><surname>Tongut</surname><given-names>A</given-names></name><name><surname>&#x000d6;zg&#x000f6;l</surname><given-names>I</given-names></name><name><surname>Mert</surname><given-names>M</given-names></name><name><surname>Kaya</surname><given-names>A</given-names></name></person-group><article-title>Oxidant status following cardiac surgery with
phosphorylcholine-coated extracorporeal circulation systems</article-title><source>Oxid Med Cell Longev</source><year>2016</year><volume>2016</volume><fpage>3932092</fpage><lpage>3932092</lpage><pub-id pub-id-type="doi">10.1155/2016/3932092</pub-id><pub-id pub-id-type="pmid">27994711</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luyten</surname><given-names>CR</given-names></name><name><surname>van Overveld</surname><given-names>FJ</given-names></name><name><surname>De Backer</surname><given-names>LA</given-names></name><name><surname>Sadowski</surname><given-names>AM</given-names></name><name><surname>Rodrigus</surname><given-names>IE</given-names></name><name><surname>De Hert</surname><given-names>SG</given-names></name><etal/></person-group><article-title>Antioxidant defence during cardiopulmonary bypass
surgery</article-title><source>Eur J Cardiothorac Surg</source><year>2005</year><volume>27</volume><issue>4</issue><fpage>611</fpage><lpage>616</lpage><pub-id pub-id-type="doi">10.1016/j.ejcts.2004.12.013</pub-id><pub-id pub-id-type="pmid">15784359</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>RW</given-names></name></person-group><article-title>Prevention of lung injury in cardiac surgery: a
review</article-title><source>J Extra Corpor Technol</source><year>2014</year><volume>46</volume><issue>2</issue><fpage>130</fpage><lpage>141</lpage><pub-id pub-id-type="pmid">25208430</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zakkar</surname><given-names>M</given-names></name><name><surname>Guida</surname><given-names>G</given-names></name><name><surname>Suleiman</surname><given-names>MS</given-names></name><name><surname>Angelini</surname><given-names>GD</given-names></name></person-group><article-title>Cardiopulmonary bypass and oxidative stress</article-title><source>Oxid Med Cell Longev</source><year>2015</year><volume>2015</volume><fpage>189863</fpage><lpage>189863</lpage><pub-id pub-id-type="doi">10.1155/2015/189863</pub-id><pub-id pub-id-type="pmid">25722792</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adly</surname><given-names>AAM</given-names></name><name><surname>ElSherif</surname><given-names>NHK</given-names></name><name><surname>Ismail</surname><given-names>EAR</given-names></name><name><surname>Ibrahim</surname><given-names>YA</given-names></name><name><surname>Niazi</surname><given-names>G</given-names></name><name><surname>Elmetwally</surname><given-names>SH</given-names></name></person-group><article-title>Ischemia-modified albumin as a marker of vascular dysfunction and
subclinical atherosclerosis in &#x003b2;-thalassemia major</article-title><source>Redox Rep</source><year>2017</year><volume>22</volume><issue>6</issue><fpage>430</fpage><lpage>438</lpage><pub-id pub-id-type="doi">10.1080/13510002.2017.1301624</pub-id><pub-id pub-id-type="pmid">28288539</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thielmann</surname><given-names>M</given-names></name><name><surname>Pasa</surname><given-names>S</given-names></name><name><surname>Holst</surname><given-names>T</given-names></name><name><surname>Wendt</surname><given-names>D</given-names></name><name><surname>Dohle</surname><given-names>DS</given-names></name><name><surname>Demircioglu</surname><given-names>E</given-names></name><etal/></person-group><article-title>Heart-type fatty acid binding protein and ischemia-modified
albumin for detection of myocardial infarction after coronary artery bypass
graft surgery</article-title><source>Ann Thorac Surg</source><year>2017</year><volume>104</volume><issue>1</issue><fpage>130</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1016/j.athoracsur.2016.10.051</pub-id><pub-id pub-id-type="pmid">28189274</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lippi</surname><given-names>G</given-names></name><name><surname>Montagnana</surname><given-names>M</given-names></name><name><surname>Salvagno</surname><given-names>GL</given-names></name><name><surname>Guidi</surname><given-names>GC</given-names></name></person-group><article-title>Standardization of ischemia-modified albumin testing: adjustment
for serum albumin</article-title><source>Clin Chem Lab Med</source><year>2007</year><volume>45</volume><issue>2</issue><fpage>261</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1515/CCLM.2007.039</pub-id><pub-id pub-id-type="pmid">17311519</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berndt</surname><given-names>C</given-names></name><name><surname>Lillig</surname><given-names>CH</given-names></name><name><surname>Holmgren</surname><given-names>A</given-names></name></person-group><article-title>Thiol-based mechanisms of the thioredoxin and glutaredoxin
systems: implications for diseases in the cardiovascular
system</article-title><source>Am J Physiol Heart Circ Physiol</source><year>2007</year><volume>292</volume><issue>3</issue><fpage>H1227</fpage><lpage>H1236</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.01162.2006</pub-id><pub-id pub-id-type="pmid">17172268</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kundi</surname><given-names>H</given-names></name><name><surname>Erel</surname><given-names>&#x000d6;</given-names></name><name><surname>Balun</surname><given-names>A</given-names></name><name><surname>&#x000c7;i&#x000e7;ek&#x000e7;ioglu</surname><given-names>H</given-names></name><name><surname>Cetin</surname><given-names>M</given-names></name><name><surname>Kiziltunc</surname><given-names>E</given-names></name><etal/></person-group><article-title>Association of thiol/disulphide ratio with syntax score in
patients with NSTEMI</article-title><source>Scan Cardiovasc J</source><year>2015</year><volume>49</volume><issue>2</issue><fpage>95</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.3109/14017431.2015.1013153</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castillo</surname><given-names>R</given-names></name><name><surname>Rodrigo</surname><given-names>R</given-names></name><name><surname>Perez</surname><given-names>F</given-names></name><name><surname>Cereceda</surname><given-names>M</given-names></name><name><surname>Asenjo</surname><given-names>R</given-names></name><name><surname>Zamorano</surname><given-names>J</given-names></name><etal/></person-group><article-title>Antioxidant therapy reduces oxidative and inflammatory tissue
damage in patients subjected to cardiac surgery with extracorporeal
circulation</article-title><source>Basic Clin Pharmacol Toxicol</source><year>2011</year><volume>108</volume><issue>4</issue><fpage>256</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1111/j.1742-7843.2010.00651.x</pub-id><pub-id pub-id-type="pmid">21138533</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhatia</surname><given-names>M</given-names></name><name><surname>Kidd</surname><given-names>B</given-names></name><name><surname>Kumar</surname><given-names>PA</given-names></name></person-group><article-title>Pro: mechanical ventilation should be continued during
cardiopulmonary bypass</article-title><source>J Cardiothorac Vascr Anesth</source><year>2018</year><volume>32</volume><issue>4</issue><fpage>1998</fpage><lpage>2000</lpage><pub-id pub-id-type="doi">10.1053/j.jvca.2018.02.031</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kar</surname><given-names>SK</given-names></name><name><surname>Ganguly</surname><given-names>T</given-names></name><name><surname>Dasgupta</surname><given-names>CS</given-names></name><name><surname>Goswami</surname><given-names>A</given-names></name></person-group><article-title>Comparison of low ventilation, no ventilation and continuous
positive pressure ventilation as pulmonary protection strategy during
cardiopulmonary bypass</article-title><source>Arch Med</source><year>2015</year><volume>7</volume><issue>1</issue><fpage>1</fpage><lpage>6</lpage></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>John</surname><given-names>LC</given-names></name><name><surname>Ervine</surname><given-names>IM</given-names></name></person-group><article-title>A study assessing the potential benefit of continued ventilation
during cardiopulmonary bypass</article-title><source>Interact Cardiovasc Thorac Surg</source><year>2008</year><volume>7</volume><fpage>14</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1510/icvts.2007.158451</pub-id><pub-id pub-id-type="pmid">17933836</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Babayigit</surname><given-names>M</given-names></name><name><surname>&#x000d6;zgencil</surname><given-names>GE</given-names></name><name><surname>&#x000c7;atav</surname><given-names>S</given-names></name><name><surname>Denker</surname><given-names>&#x000c7;E</given-names></name><name><surname>Babayigit</surname><given-names>MA</given-names></name></person-group><article-title>Effect of ventilation during cardiopulmonary bypass in open heart
surgery on postoperative pulmonary functions</article-title><source>J Anesth</source><year>2012</year><volume>20</volume><issue>2</issue><fpage>92</fpage><lpage>98</lpage></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chi</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Ventilation during cardiopulmonary bypass for prevention of
respiratory insufficiency: a meta-analysis of randomized controlled
trials</article-title><source>Medicine</source><year>2017</year><volume>96</volume><issue>12</issue><elocation-id>e6454</elocation-id><pub-id pub-id-type="doi">10.1097/MD.0000000000006454</pub-id><pub-id pub-id-type="pmid">28328860</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durukan</surname><given-names>AB</given-names></name><name><surname>Gurbuz</surname><given-names>HA</given-names></name><name><surname>Salman</surname><given-names>N</given-names></name><name><surname>Unal</surname><given-names>EU</given-names></name><name><surname>Ucar</surname><given-names>HI</given-names></name><name><surname>Yorgancioglu</surname><given-names>C</given-names></name></person-group><article-title>Ventilation during cardiopulmonary bypass did not attenuate
inflammatory response or affect postoperative outcomes</article-title><source>Cardiovasc J Afr</source><year>2013</year><volume>24</volume><issue>6</issue><fpage>224</fpage><lpage>230</lpage><pub-id pub-id-type="doi">10.5830/CVJA-2013-041</pub-id><pub-id pub-id-type="pmid">24217262</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erel</surname><given-names>O</given-names></name><name><surname>Neselioglu</surname><given-names>S</given-names></name></person-group><article-title>A novel and automated assay for thiol/disulphide
homeostasis</article-title><source>Clin Biochem</source><year>2014</year><volume>47</volume><issue>18</issue><fpage>326</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.1016/j.clinbiochem.2014.09.026</pub-id><pub-id pub-id-type="pmid">25304913</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bar-Or</surname><given-names>D</given-names></name><name><surname>Lau</surname><given-names>E</given-names></name><name><surname>Winkler</surname><given-names>JV</given-names></name></person-group><article-title>A novel assay for cobalt albumin binding and its potential as a
marker for myocardial ischemia-a preliminary report</article-title><source>J Emerg Med</source><year>2000</year><volume>19</volume><issue>4</issue><fpage>311</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.1016/S0736-4679(00)00255-9</pub-id><pub-id pub-id-type="pmid">11074321</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanko</surname><given-names>M</given-names></name><name><surname>Yavuz</surname><given-names>S</given-names></name><name><surname>Duman</surname><given-names>C</given-names></name><name><surname>Hosten</surname><given-names>T</given-names></name><name><surname>Oner</surname><given-names>E</given-names></name><name><surname>Berki</surname><given-names>T</given-names></name></person-group><article-title>Ischemia-modified albumin use as a prognostic factor in coronary
bypass surgery</article-title><source>J Cardiothorac Surg</source><year>2012</year><volume>7</volume><fpage>3</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1186/1749-8090-7-3</pub-id><pub-id pub-id-type="pmid">22221979</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vogt</surname><given-names>S</given-names></name><name><surname>Sattler</surname><given-names>A</given-names></name><name><surname>Sirat</surname><given-names>AS</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>B</given-names></name><name><surname>Seifart</surname><given-names>C</given-names></name><name><surname>Maisch</surname><given-names>B</given-names></name><etal/></person-group><article-title>Different profile of antioxidative capacity results in pulmonary
dysfunction and amplified inflammatory response after CABG
surgery</article-title><source>J Surg Res</source><year>2007</year><volume>139</volume><issue>1</issue><fpage>136</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1016/j.jss.2006.09.011</pub-id><pub-id pub-id-type="pmid">17291533</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beer</surname><given-names>L</given-names></name><name><surname>Warszawska</surname><given-names>JM</given-names></name><name><surname>Schenk</surname><given-names>P</given-names></name><name><surname>Debreceni</surname><given-names>T</given-names></name><name><surname>Dworschak</surname><given-names>M</given-names></name><name><surname>Roth</surname><given-names>GA</given-names></name><etal/></person-group><article-title>Intraoperative ventilation strategy during cardiopulmonary by
pass attenuates the release of matrix metalloproteinases and improves
oxygenation</article-title><source>J Surg Res</source><year>2015</year><volume>195</volume><issue>1</issue><fpage>294</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1016/j.jss.2014.12.022</pub-id><pub-id pub-id-type="pmid">25577145</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrando</surname><given-names>C</given-names></name><name><surname>Soro</surname><given-names>M</given-names></name><name><surname>Belda</surname><given-names>FJ</given-names></name></person-group><article-title>Protection strategies during cardiopulmonary bypass: ventilation,
anesthetics and oxygen</article-title><source>Curr Opin Anaesthesiol</source><year>2015</year><volume>28</volume><issue>1</issue><fpage>73</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1097/ACO.0000000000000143</pub-id><pub-id pub-id-type="pmid">25486490</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altiparmak</surname><given-names>IH</given-names></name><name><surname>Erkus</surname><given-names>ME</given-names></name><name><surname>Sezen</surname><given-names>H</given-names></name><name><surname>Demirbag</surname><given-names>R</given-names></name><name><surname>Gunebakmaz</surname><given-names>O</given-names></name><name><surname>Kaya</surname><given-names>Z</given-names></name><etal/></person-group><article-title>The relation of serum thiol levels and thiol/disulphide
homeostasis with the severity of coronary artery disease</article-title><source>Kardiol Pol</source><year>2016</year><volume>74</volume><issue>11</issue><fpage>1346</fpage><lpage>1353</lpage><pub-id pub-id-type="doi">10.5603/KP.a2016.0085</pub-id><pub-id pub-id-type="pmid">27221962</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kundi</surname><given-names>H</given-names></name><name><surname>Ates</surname><given-names>I</given-names></name><name><surname>Kiziltunc</surname><given-names>E</given-names></name><name><surname>Cetin</surname><given-names>M</given-names></name><name><surname>Cicekcioglu</surname><given-names>H</given-names></name><name><surname>Neselioglu</surname><given-names>S</given-names></name><etal/></person-group><article-title>A novel oxidative stress marker in acute myocardial infarction;
thiol/disulphide homeostasis</article-title><source>Am J Emerg Med</source><year>2015</year><volume>33</volume><issue>11</issue><fpage>1567</fpage><lpage>1571</lpage><pub-id pub-id-type="doi">10.1016/j.ajem.2015.06.016</pub-id><pub-id pub-id-type="pmid">26143314</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>D</given-names></name><name><surname>Quiles</surname><given-names>J</given-names></name><name><surname>Gaze</surname><given-names>DC</given-names></name><name><surname>Collinson</surname><given-names>P</given-names></name><name><surname>Kaski</surname><given-names>JC</given-names></name><name><surname>Baxter</surname><given-names>GF</given-names></name></person-group><article-title>Role of reactive oxygen species on the formation of the novel
diagnostic marker ischaemia modified albumin</article-title><source>Heart</source><year>2006</year><volume>92</volume><issue>1</issue><fpage>113</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1136/hrt.2004.049643</pub-id><pub-id pub-id-type="pmid">16365361</pub-id></element-citation></ref></ref-list></back></article>